Intraventricular Hemorrhage clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Clinical Efficacy and Safety Study of OHB-607 in Preventing Chronic Lung Disease in Extremely Premature Infants
Sorry, in progress, not accepting new patients
The purpose of this study is to determine if an investigational drug can reduce the burden of chronic lung disease in extremely premature infants, as compared to extremely premature infants receiving standard neonatal care alone.
Los Angeles, California and other locations
Our lead scientists for Intraventricular Hemorrhage research studies include Meena Garg.
Last updated: